Clinical Trial Update: Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk [NA]

View source ↗

Summary

A clinical trial update assessing safety and efficacy of de-escalating dual antiplatelet therapy after BioFreedom stenting in acute coronary syndrome patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR) | NA | Status: NOT_YET_RECRUITING